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Fine structural analyses of nerve terminals in both
the central and in the peripheral nervous systems
have demonstrated the presence of synaptic ves-
icles, which were postulated to be the storage sites
of neurotransmitters. Several different types of
synaptic vesicles have been described (see ref. 6).
Electron-lucent vesices, 400-500 A in diameter,
constitute the most commonly occurring type in
central and in peripheral synapses . Because they
are consistently found in cholinergic nerve termi-
nals, these vesicles were postulated to constitute
the site of acetylcholine storage, an assumption
confirmed by isolation studies (8). Granulated
vesicles, 300-500 A in diameter, with an electron-
opaque core are characteristic of peripheral ad-
renergic terminals (7). Combined pharmacological
and electron microscopical studies have shown that
these vesicles contain norepinephrine (NE) (19,
20) and also, in nerve endings of rat pineal gland,
5-hydroxytryptamine (5-HT) (16). The presence
of another type of vesicle, a larger one (800-1000
A in diameter) which possesses an internal content
of variable density, has been also observed . These
large granulated vesicles (LGV) occur in terminals
which also contain electron-lucent or granulated
vesicles, e.g. postganglionic sympathetic terminals,
endings in the sphincter pupillae, preganglionic
cholinergic fibers to sympathetic ganglia, pregan-
glionic terminals supplying the adrenal medulla,
parasympathetic ganglia, endings and neuronal
perikarya of the central nervous system (CNS) of
areas rich or poor in monoamines in both verte-
brates and invertebrates, stumps of injured periph-
eral nerves or central tracts, etc. (for bibliography
see ref. 12). There is not yet general agreement
concerning the significance of the LGV .
When phosphotungstic acid is added to the
absolute ethanol (E-PTA) during the dehydration
of glutaraldehyde-fixed tissue, the dense cores of
the LGV in the CNS seem to be specifically
stained (1) . In order to determine the relationship
between the LGV in peripheral nerve endings and
those of CNS terminals, the reactivity of the former
to E-PTA was studied. The possible participation
of biogenic amines in the reaction was also
analyzed.
MATERIAL AND METHODS
Pineal glands and vas deferens from normal adult
rats, and from rats receiving 10 mg/kg of reserpine
(Serpasol, Ciba) intraperitoneally 6 hr before decap-
itation, were fixed in 37 c glutaraldehyde in 0.2 M
cacodylate buffer, pH 7 .2, for 4 hr at 4 °C. After
washing in 0.3 M sucrose in the same buffer, some
blocks were postfixed for 2 hr in 1.5% buffered
osmium tetroxide, and others in 2.57 potassium
dichromate in 0.2 M acetate buffer pH 4.1 as pre-
viously described (14) . The remaining blocks were
directly dehydrated in ethanol after glutaraldehyde
fixation and were immersed for 1 hr in 1 0 / 0 phospho-
tungstic acid in absolute ethanol (E-PTA) essentially
as described by Bloom and Aghajanian (1, 3) . The
superior cervical ganglion, median eminence and
suprachiasmatic nucleus of normal rats were sim-
ilarly fixed and stained with osmium tetroxide and
with E-PTA. Embedding was done in Epon 812.
Thin sections of material which had been processed
with glutaraldehyde-osmium tetroxide were stained
with lead citrate, and the rest were examined with-
out further staining under a Siemens Elmiskop I
electron microscope.
OBSERVATIONS
In adrenergic nerve endings lying in the perivas-
cular space of the pineal gland, two different types
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855Figures 1 to 9. The magnification line corresponds to 0.5 p in all figures.
FIGURE 1 The E-PTA positive reaction is observed in a dense sphere (arrow) in an adrenergic nerve
ending of the perivascular space of a normal pineal gland . Glutaraldehyde-E-PTA . X 39,000.
FIGURE 2 Sympathetic nerve endings in the pineal gland exhibiting both small and large (arrows)
granulated vesicles. Glutaraldehyde-Os04 . X 31,000.
FIGURE 3 Clusters of granules reacting with dichromate that correspond to a pineal nerve ending .
Reactive sites, corresponding to the cores of both small and large granulated vesicles (arrows), are seen.
Glutaraldehyde-dichromate . X 46,000.
of granulated vesicles may be observed after
glutaraldehyde-osmium tetroxide fixation (Fig. 2)
numerous small vesicles (SGV) about 400 A in
diameter and a few larger vesicles (LGV) 800-
1000 A in diameter . The storage of monoamines
in the cores of both types of vesicles is demonstrated
by the reaction given with the glutaraldehyde-
dichromate procedure (Fig. 3) . In nerve endings
of pineal glands fixed in glutaraldehyde and
stained with E-PTA, reactive sites were observed
which corresponded in size and in frequency to the
cores of the LGV (Fig. 1). No limiting membrane
was observed surrounding the reactive core.
Therefore, absolute correlation between the cores
revealed by E-PTA and those demonstrated by
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conventional techniques could not be made .
However, with these limitations in mind and
because of the similarities listed above, the reactive
sites demonstrated by E-PTA were assumed to
correspond to the cores of the LGV. Reserpine
administration caused disappearance of the cores
of the SGV in glutaraldehyde-osmium tetroxide-
fixed tissue, while the cores of the LGV remained
unaltered (Fig. 5). The absence of reaction with
glutaraldehyde-dichromate (Fig 6) reflected the
degree of monoamine depletion and confirmed
that both types of granulated vesicles participate
in monoamine storage. Nevertheless, the E-PTA
reactive material observed in nerves of normal
pineal glands showed no change following reser-FIGURE 4 A pineal nerve ending of a rat given reserpine . Note that the circular densities appearing in the
ending after E-PTA exposure are unaffected by the treatment . Glutaraldehyde-E-PTA . X 43,000.
FIGURE 5 The dense cores of the small vesicles have disappeared from these endings in a rat receiving
reserpine. A large granulated vesicle is seen (arrow) . Glutaraldehyde-OsOI . X 35,000.
FIGURE 6 After reserpine administration no reaction is observed in the nerve endings treated with
dichromate. Glutaraldehyde-dichromate. X 40,000.
pine (Fig. 4). Similar observations were made in
the nerves of the vas deferens.
The nerve processes lying between cells of the
superior cervical ganglion and identified as belong-
ing to preganglionic cholinergic fibers showed the
presence of numerous small, clear vesicles and
some LGV (Fig. 7 a). After exposure to E-PTA,
the cores of what were probably LGV could be
recognized (Fig. 7 b) .
Two different types of central synapses were
studied with the E-PTA staining : those of the
outer zone of the median eminence and those of
the suprachiasmatic nucleus, in which fluorescence
histochemical methods have demonstrated dopa-
mine and 5-HT, respectively (10). In both types
of synapses the vesicular population is composed of
clear vesicles and LGV (Figs . 8 a and 9 a) . The
E-PTA stain discloses in both terminals spherical
or annular densities (Figs. 8 b and 9 b) matching in
size, location, and frequency the cores of LGV
observed with conventional techniques .
In accordance with previous studies of E-PTA
staining in the CNS (1, 3), the material present at
synaptic junctions as well as at nuclei, nucleoli,
and erythrocytic membranes was found to stain
with E-PTA.
DISCUSSION
Previous studies have shown that in peripheral
adrenergic terminals the cores of the small granu-
lated vesicles (SGV) disappear after monoamine
depletion (18, 19) while those of the large granu-
lated vesicles (LGV) remain unaltered (4, 5, 9, 13).
These results, obtained with osmium tetroxide or
B R I E F N O T E S
	
857FIGURE 7 a A nerve process in the superior cervical ganglion is shown containing a mixed population of
clear vesicles and LGV (arrows). Glutaraldehyde-Os04 . X 30,000. In Fig. 7 b, the sites staining with
E-PTA are seen and correspond to the cores of the LGV . Glutaraldehyde - E-PTA. X 30,000.
FIGURE 8 a External layer of the median eminence in which nerve terminals, containing clear vesicles and
LGV, are observed . Glutaraldehyde-Os04 . X 19,000. In Fig. 8 b, the reactive sites appearing after E-PTA
are apparent and roughly correspond in size and distribution to the LGV observed in Fig . 8a. Glutaralde-
hyde-E-PTA. X 19,000.
FIGURE 9 a A neural process in the suprachiasmatic nucleus showing small electron-lucent vesicles and
LGV. Glutaraldehyde-Os04 . X 37,000. In Fig. 9 b, E-PTA staining of a similar structure shows reactive
spherical sites that probably correspond to the cores of the LGV. Glutaraldehyde-E-PTA . X 37,000.
858glutaraldehyde-osmium tetroxide fixation, were
interpreted as an indication that LGV normally
do not store monoamines . However, the first direct
evidence that the LGV store NE and 5-HT in the
adrenergic nerves of the pineal gland and NE in
the vas deferens was provided by the use of selec-
tive cytochemical techniques for monoamines (16) .
In depletion experiments it was found that the
LGV reacted in the same manner as the small
granulated vesicles (22) and also behaved similarly
with respect to amine storage and uptake (17).
That the E-PTA staining is independent of the
content of monoamines is demonstrated by the
fact that only the LGV display a positive reaction
in endings in which amines are also stored in
SGV. Moreover, the E-PTA staining of LGV in
peripheral adrenergic endings persists after reser-
pine treatment which, as shown by the cytochemi-
cal reaction, depletes NE and 5-HT present in
those vesicles. These findings support the hypothe-
sis that the cores of LGV in peripheral nerves con-
tain at least two electron-opaque components (22),
i.e., the biogenic amine revealed by specific cyto-
chemical reactions, and the E-PTA positive sub-
stance, which is resistant to reserpine treatment
and probably corresponds to the osmiophilic core
observed in those vesicles after amine depletion .
The localization of amine stores in central
adrenergic synapses is still uncertain because of
the technical difficulties posed by the handling of
brain tissue for ultrastructural and cytochemical
analysis. In these synapses, LGV occur associated
with small electron-lucent vesicles (21) and,
although several studies suggested that they con-
stitute the storage site of monoamines, the evidence
regarding their change in number or electron
opacity with pharmacological treatments has been
controversial (2). The use of conventional tech-
niques for electron microscopy may interfere with
the detection of these changes, as was the case of
LGV in peripheral nerves (22) . Several ultrastruc-
tural and cytochemical characteristics are shared
by both central and peripheral monoaminergic
endings, i.e., the demonstration of monoamines by
the glutaraldehyde-dichromate procedure in LGV
of hypothalamic (24) as well as of peripheral (16)
adrenergic endings; the demonstration of SGV
characteristic of peripheral adrenergic nerves in
various central adrenergic terminals by perman-
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